# All Registered Polls

The table below lists all polls registered and analyzed so far.

| Period     | Polling firm/Commissioner(s) | ÖVP | SPÖ | FPÖ | Grüne | NEOS | JETZT | GILT | HC |
|:----------:|:----------------------------:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| 26 May 2019 | General Election | 34.6% <br> 7 | 23.9% <br> 5 | 17.2% <br> 3 | 14.1% <br> 2 | 8.4% <br> 1 | 1.0% <br> 0 | 0.0% <br> 0 | 0.0% <br> 0 |
| [23–28 December 2021](2021-12-28-Market.html) | Market <br> Der Standard | 21–27% <br> 4–6 | 23–29% <br> 5–6 | 18–24% <br> 4–5 | 10–14% <br> 2–3 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–16 December 2021](2021-12-16-PeterHajek.html) | Peter Hajek <br> APA and ATV | 24–30% <br> 5–6 | 22–28% <br> 4–6 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 December 2021](2021-12-09-UniqueResearch.html) | Unique Research <br> profil | 24–30% <br> 5–6 | 24–30% <br> 5–6 | 15–20% <br> 3–4 | 9–13% <br> 1–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 December 2021](2021-12-09-Market.html) | Market <br> Der Standard | 21–27% <br> 4–6 | 23–29% <br> 5–6 | 19–25% <br> 4–5 | 10–14% <br> 2–3 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 December 2021](2021-12-09-IFDD.html) | IFDD <br> PULS 24 | 20–27% <br> 4–5 | 23–30% <br> 4–6 | 17–23% <br> 3–5 | 10–15% <br> 2–3 | 10–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 November 2021](2021-11-25-OGM.html) | OGM <br> KURIER | 20–26% <br> 4–5 | 23–29% <br> 5–6 | 18–24% <br> 4–5 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–18 November 2021](2021-11-18-UniqueResearch.html) | Unique Research <br> profil | 21–27% <br> 4–6 | 22–28% <br> 4–6 | 17–23% <br> 3–5 | 11–16% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 November 2021](2021-11-11-UniqueResearch.html) | Unique Research <br> Heute | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–21 October 2021](2021-10-21-PeterHajek.html) | Peter Hajek <br> APA and ATV | 20–26% <br> 4–5 | 20–26% <br> 4–5 | 17–23% <br> 3–5 | 14–19% <br> 3–4 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–15 October 2021](2021-10-15-UniqueResearch.html) | Unique Research <br> profil | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–15 October 2021](2021-10-15-OGM.html) | OGM <br> KURIER | 24–29% <br> 5–6 | 22–27% <br> 4–5 | 19–23% <br> 4–5 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–12 October 2021](2021-10-12-Market.html) | Market <br> Der Standard | 24–30% <br> 5–6 | 22–28% <br> 4–6 | 18–24% <br> 4–5 | 9–13% <br> 1–2 | 11–16% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–11 October 2021](2021-10-11-IFDD.html) | IFDD | 24–28% <br> 5–6 | 23–27% <br> 4–5 | 19–23% <br> 4 | 10–13% <br> 2 | 10–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28–30 September 2021](2021-09-30-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30–38% <br> 6–8 | 19–26% <br> 4–5 | 12–18% <br> 2–4 | 8–13% <br> 1–2 | 7–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–9 September 2021](2021-09-09-OGM.html) | OGM <br> KURIER | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 August–1 September 2021](2021-09-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–26 August 2021](2021-08-26-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–19 August 2021](2021-08-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–12 August 2021](2021-08-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–11 August 2021](2021-08-11-Market.html) | Market <br> Der Standard | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–5 August 2021](2021-08-05-UniqueResearch.html) | Unique Research <br> profil | 32–38% <br> 6–8 | 18–24% <br> 3–5 | 16–22% <br> 3–4 | 10–14% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–5 August 2021](2021-08-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–29 July 2021](2021-07-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 July 2021](2021-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 17–24% <br> 3–5 | 15–22% <br> 3–4 | 9–15% <br> 2–3 | 8–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–21 July 2021](2021-07-21-IFDD.html) | IFDD <br> PULS 24 | 32–38% <br> 6–8 | 19–25% <br> 4–5 | 16–22% <br> 3–4 | 9–13% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–15 July 2021](2021-07-15-ResearchAffairs.html) | Research Affairs <br> PULS | 32–38% <br> 7–8 | 18–23% <br> 3–5 | 16–21% <br> 3–4 | 9–13% <br> 2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–8 July 2021](2021-07-08-UniqueResearch.html) | Unique Research <br> profil | 31–37% <br> 6–8 | 19–25% <br> 4–5 | 15–20% <br> 3–4 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–8 July 2021](2021-07-08-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–38% <br> 7–8 | 19–24% <br> 4–5 | 15–19% <br> 3–4 | 9–13% <br> 2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 June–2 July 2021](2021-07-02-IFDD.html) | IFDD <br> PULS 24 | 30–36% <br> 6–7 | 21–27% <br> 4–5 | 15–21% <br> 3–4 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 June–1 July 2021](2021-07-01-UniqueResearch.html) | Unique Research <br> Heute | 32–38% <br> 6–8 | 19–25% <br> 4–5 | 15–20% <br> 3–4 | 11–16% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 June–1 July 2021](2021-07-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30–38% <br> 6–8 | 19–26% <br> 4–5 | 13–19% <br> 2–4 | 9–14% <br> 1–3 | 9–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29–30 June 2021](2021-06-30-Market.html) | Market <br> Der Standard | 28–34% <br> 6–7 | 23–29% <br> 5–6 | 15–20% <br> 3–4 | 11–16% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–24 June 2021](2021-06-24-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30–38% <br> 6–8 | 20–27% <br> 4–5 | 13–19% <br> 2–4 | 9–15% <br> 2–3 | 9–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–24 June 2021](2021-06-24-PeterHajek.html) | Peter Hajek | 31–37% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 9–13% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–24 June 2021](2021-06-24-OGM.html) | OGM <br> KURIER | 30–36% <br> 6–7 | 22–28% <br> 4–6 | 15–21% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 June 2021](2021-06-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–38% <br> 6–8 | 20–25% <br> 4–5 | 13–17% <br> 2–3 | 10–14% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–15 June 2021](2021-06-15-IFDD.html) | IFDD <br> PULS 24 | 29–35% <br> 6–7 | 24–30% <br> 5–6 | 16–21% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–10 June 2021](2021-06-10-UniqueResearch.html) | Unique Research <br> profil | 30–36% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 11–16% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–10 June 2021](2021-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 19–27% <br> 4–5 | 11–17% <br> 2–3 | 9–15% <br> 2–3 | 9–15% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–10 June 2021](2021-06-10-Market.html) | Market <br> Der Standard | 29–35% <br> 6–7 | 24–30% <br> 5–6 | 14–19% <br> 2–4 | 11–15% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [31 May–2 June 2021](2021-06-02-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 20–28% <br> 4–6 | 12–18% <br> 2–4 | 9–14% <br> 1–3 | 9–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–30 May 2021](2021-05-30-Market.html) | Market | 26–32% <br> 5–6 | 25–31% <br> 5–6 | 18–23% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25–27 May 2021](2021-05-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30–38% <br> 6–8 | 20–27% <br> 4–5 | 13–19% <br> 2–4 | 9–14% <br> 1–3 | 9–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–20 May 2021](2021-05-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30–38% <br> 6–8 | 19–26% <br> 4–5 | 14–20% <br> 3–4 | 9–14% <br> 1–3 | 10–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [14 May 2021](2021-05-14-DemoxResearch.html) | Demox Research | 30–36% <br> 6–8 | 20–26% <br> 4–5 | 16–21% <br> 3–4 | 10–14% <br> 2–3 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–13 May 2021](2021-05-13-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 19–26% <br> 4–5 | 14–21% <br> 3–4 | 9–15% <br> 2–3 | 9–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–12 May 2021](2021-05-12-UniqueResearch.html) | Unique Research <br> profil | 31–37% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–6 May 2021](2021-05-06-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 6–8 | 18–25% <br> 3–5 | 14–21% <br> 3–4 | 9–15% <br> 2–3 | 8–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–29 April 2021](2021-04-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 7–8 | 17–24% <br> 3–5 | 13–19% <br> 2–4 | 9–15% <br> 2–3 | 9–15% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [26–29 April 2021](2021-04-29-PeterHajek.html) | Peter Hajek <br> APA and ATV | 30–36% <br> 6–8 | 22–28% <br> 4–6 | 15–21% <br> 3–4 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 April 2021](2021-04-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 6–8 | 18–25% <br> 3–5 | 13–19% <br> 2–4 | 9–15% <br> 2–3 | 9–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–8 April 2021](2021-04-08-UniqueResearch.html) | Unique Research <br> profil | 30–36% <br> 6–8 | 21–27% <br> 4–5 | 16–22% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 March–1 April 2021](2021-04-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33–39% <br> 7–8 | 19–24% <br> 4–5 | 16–21% <br> 3–4 | 7–11% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 March–1 April 2021](2021-04-01-OGM.html) | OGM <br> KURIER | 32–38% <br> 6–8 | 21–27% <br> 4–5 | 15–20% <br> 3–4 | 9–13% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [26–30 March 2021](2021-03-30-Market.html) | Market <br> Der Standard | 33–39% <br> 7–8 | 23–29% <br> 4–6 | 13–18% <br> 2–3 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 March 2021](2021-03-25-UniqueResearch.html) | Unique Research <br> Heute | 33–39% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 March 2021](2021-03-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 6–8 | 19–26% <br> 3–5 | 14–21% <br> 3–4 | 7–12% <br> 1–2 | 9–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 March 2021](2021-03-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33–41% <br> 7–9 | 20–28% <br> 4–6 | 13–20% <br> 2–4 | 7–12% <br> 1–2 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 March 2021](2021-03-11-PeterHajek.html) | Peter Hajek <br> APA and ATV | 32–38% <br> 6–8 | 22–28% <br> 4–6 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [1–4 March 2021](2021-03-04-UniqueResearch.html) | Unique Research <br> profil | 32–38% <br> 6–8 | 21–27% <br> 4–5 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–4 March 2021](2021-03-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33–41% <br> 7–9 | 19–27% <br> 4–5 | 14–21% <br> 3–4 | 7–12% <br> 1–2 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–18 February 2021](2021-02-18-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33–41% <br> 7–9 | 20–28% <br> 4–6 | 14–20% <br> 3–4 | 6–11% <br> 1–2 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 February 2021](2021-02-17-Market.html) | Market <br> Der Standard | 34–40% <br> 7–8 | 22–28% <br> 4–6 | 12–16% <br> 2–3 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 February 2021](2021-02-11-UniqueResearch.html) | Unique Research <br> profil | 33–39% <br> 7–8 | 20–26% <br> 4–5 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 February 2021](2021-02-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 34–42% <br> 7–9 | 20–28% <br> 4–6 | 13–19% <br> 2–4 | 7–12% <br> 1–2 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [1–4 February 2021](2021-02-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–43% <br> 7–9 | 20–28% <br> 4–6 | 12–18% <br> 2–4 | 7–12% <br> 1–2 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25 January–1 February 2021](2021-02-01-IFDD.html) | IFDD <br> Kronen Zeitung | 32–38% <br> 6–8 | 21–27% <br> 4–5 | 15–21% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–14 January 2021](2021-01-14-UniqueResearch.html) | Unique Research <br> profil | 34–40% <br> 7–8 | 19–25% <br> 4–5 | 14–19% <br> 2–4 | 12–17% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–7 January 2021](2021-01-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 20–26% <br> 4–5 | 14–18% <br> 3–4 | 7–11% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–21 December 2020](2020-12-21-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 20–26% <br> 4–5 | 11–15% <br> 2–3 | 12–17% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 December 2020](2020-12-17-OGM.html) | OGM <br> KURIER | 37–44% <br> 7–9 | 20–26% <br> 4–5 | 11–16% <br> 2–3 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–12 December 2020](2020-12-12-PeterHajek.html) | Peter Hajek <br> APA and ATV | 36–42% <br> 7–9 | 19–25% <br> 4–5 | 14–19% <br> 2–4 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5 December 2020](2020-12-05-UniqueResearch.html) | Unique Research <br> profil | 37–43% <br> 7–9 | 17–23% <br> 3–5 | 13–18% <br> 2–3 | 11–16% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 November–3 December 2020](2020-12-03-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–44% <br> 7–9 | 19–26% <br> 4–5 | 10–16% <br> 2–3 | 8–13% <br> 1–2 | 9–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | 1–4% <br> 0 |
| [30 November–2 December 2020](2020-12-02-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 20–26% <br> 4–5 | 12–17% <br> 2–3 | 12–17% <br> 2–3 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–19 November 2020](2020-11-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37–45% <br> 8–10 | 19–26% <br> 4–5 | 9–15% <br> 2–3 | 9–14% <br> 1–3 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 1–4% <br> 0 |
| [9–12 November 2020](2020-11-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 38–44% <br> 8–9 | 20–25% <br> 4–5 | 10–14% <br> 2–3 | 9–13% <br> 2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 1–3% <br> 0 |
| [5–7 November 2020](2020-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–44% <br> 7–9 | 18–25% <br> 3–5 | 8–14% <br> 1–3 | 8–14% <br> 1–3 | 7–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 2–5% <br> 0–1 |
| [2–6 November 2020](2020-11-06-UniqueResearch.html) | Unique Research | 35–41% <br> 7–9 | 18–24% <br> 4–5 | 14–19% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–29 October 2020](2020-10-29-ResearchAffairs.html) | Research Affairs | 36–44% <br> 7–10 | 19–26% <br> 4–5 | 8–13% <br> 1–2 | 9–14% <br> 1–3 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 3–6% <br> 0–1 |
| [20–22 October 2020](2020-10-22-ResearchAffairs.html) | Research Affairs | 37–45% <br> 8–10 | 18–25% <br> 3–5 | 8–13% <br> 1–2 | 9–15% <br> 2–3 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 3–6% <br> 0–1 |
| [20–22 October 2020](2020-10-22-OGM.html) | OGM | 38–42% <br> 8–9 | 21–25% <br> 4–5 | 10–13% <br> 2 | 14–18% <br> 3 | 7–9% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–16 October 2020](2020-10-16-UniqueResearch.html) | Unique Research | 37–43% <br> 7–9 | 19–25% <br> 4–5 | 11–16% <br> 2–3 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–8 October 2020](2020-10-08-ResearchAffairs.html) | Research Affairs | 37–45% <br> 8–10 | 16–23% <br> 3–5 | 9–14% <br> 1–3 | 9–15% <br> 2–3 | 7–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 4–8% <br> 0–1 |
| [28–30 September 2020](2020-09-30-ResearchAffairs.html) | Research Affairs | 37–45% <br> 8–10 | 17–24% <br> 3–5 | 9–14% <br> 1–3 | 9–15% <br> 2–3 | 7–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 3–7% <br> 0–1 |
| [21–24 September 2020](2020-09-24-ResearchAffairs.html) | Research Affairs | 37–45% <br> 8–10 | 17–24% <br> 3–5 | 9–15% <br> 2–3 | 9–15% <br> 2–3 | 7–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 3–6% <br> 0–1 |
| [14–18 September 2020](2020-09-18-UniqueResearch.html) | Unique Research | 36–42% <br> 7–9 | 17–23% <br> 3–4 | 14–19% <br> 2–4 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [14–16 September 2020](2020-09-16-ResearchAffairs.html) | Research Affairs | 39–45% <br> 8–10 | 17–22% <br> 3–4 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25–27 August 2020](2020-08-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37–45% <br> 8–10 | 16–23% <br> 3–5 | 10–16% <br> 2–3 | 11–17% <br> 2–3 | 6–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 3–6% <br> 0–1 |
| [17–20 August 2020](2020-08-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 38–46% <br> 8–10 | 16–23% <br> 3–5 | 10–16% <br> 2–3 | 12–18% <br> 2–4 | 6–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 2–5% <br> 0–1 |
| [10–13 August 2020](2020-08-13-UniqueResearch.html) | Unique Research <br> profil | 38–44% <br> 8–9 | 15–21% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 July 2020](2020-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 38–46% <br> 8–10 | 16–23% <br> 3–5 | 9–14% <br> 1–3 | 12–18% <br> 2–4 | 6–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 3–6% <br> 0–1 |
| [13–16 July 2020](2020-07-16-UniqueResearch.html) | Unique Research <br> profil | 38–44% <br> 8–9 | 16–22% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 July 2020](2020-07-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37–45% <br> 8–10 | 17–24% <br> 3–5 | 8–14% <br> 1–3 | 12–18% <br> 2–4 | 6–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | 2–5% <br> 0–1 |
| [23–25 June 2020](2020-06-25-OGM.html) | OGM | 39–45% <br> 8–10 | 16–22% <br> 3–4 | 11–16% <br> 2–3 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–12 June 2020](2020-06-12-UniqueResearch.html) | Unique Research <br> profil | 41–47% <br> 8–10 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–10 June 2020](2020-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39–45% <br> 8–10 | 17–22% <br> 3–4 | 10–14% <br> 2–3 | 14–18% <br> 3–4 | 6–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | 2–4% <br> 0 |
| [5–9 June 2020](2020-06-09-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 39–45% <br> 8–10 | 17–22% <br> 3–4 | 11–15% <br> 2–3 | 13–17% <br> 2–3 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25–28 May 2020](2020-05-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 40–46% <br> 8–10 | 16–21% <br> 3–4 | 10–14% <br> 2–3 | 14–18% <br> 3–4 | 6–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | 2–4% <br> 0 |
| [21–26 May 2020](2020-05-26-Market.html) | Market <br> Der Standard | 41–47% <br> 8–10 | 17–23% <br> 3–4 | 10–14% <br> 2–3 | 14–19% <br> 2–4 | 5–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–19 May 2020](2020-05-19-Market.html) | Market <br> Der Standard | 40–46% <br> 8–9 | 19–24% <br> 4–5 | 10–14% <br> 2–3 | 15–19% <br> 3–4 | 5–8% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–14 May 2020](2020-05-14-UniqueResearch.html) | Unique Research <br> profil | 43–49% <br> 9–10 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 13–18% <br> 2–3 | 5–8% <br> 0–1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–13 May 2020](2020-05-13-Market.html) | Market <br> Der Standard | 41–47% <br> 8–10 | 19–24% <br> 3–5 | 9–13% <br> 1–2 | 15–19% <br> 3–4 | 5–8% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 April 2020](2020-04-22-Market.html) | Market | 41–47% <br> 8–10 | 18–23% <br> 3–4 | 8–12% <br> 1–2 | 16–21% <br> 3–4 | 6–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–16 April 2020](2020-04-16-UniqueResearch.html) | Unique Research <br> profil | 45–51% <br> 9–11 | 14–19% <br> 2–4 | 11–16% <br> 2–3 | 14–19% <br> 2–4 | 5–8% <br> 0–1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–7 April 2020](2020-04-07-Market.html) | Market <br> Der Standard | 42–46% <br> 8–10 | 17–21% <br> 3–4 | 10–13% <br> 2 | 17–21% <br> 3–4 | 5–7% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [31 March–2 April 2020](2020-04-02-OGM.html) | OGM | 42–48% <br> 9–10 | 14–19% <br> 2–4 | 10–14% <br> 2–3 | 15–21% <br> 3–4 | 5–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–31 March 2020](2020-03-31-Market.html) | Market <br> Der Standard | 40–46% <br> 8–10 | 17–22% <br> 3–4 | 9–13% <br> 1–2 | 17–22% <br> 3–4 | 6–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–13 March 2020](2020-03-13-UniqueResearch.html) | Unique Research | 36–42% <br> 7–9 | 14–19% <br> 3–4 | 15–20% <br> 3–4 | 14–19% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–12 March 2020](2020-03-12-Market.html) | Market <br> Der Standard | 37–43% <br> 7–9 | 18–23% <br> 3–4 | 11–15% <br> 2–3 | 15–19% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–11 March 2020](2020-03-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37–43% <br> 8–9 | 15–20% <br> 3–4 | 10–14% <br> 2–3 | 15–20% <br> 3–4 | 8–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–27 February 2020](2020-02-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 15–20% <br> 3–4 | 9–13% <br> 2 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–14 February 2020](2020-02-14-UniqueResearch.html) | Unique Research <br> profil | 35–41% <br> 7–9 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–12 February 2020](2020-02-12-ResearchAffairs.html) | Research Affairs | 35–43% <br> 7–9 | 15–21% <br> 3–4 | 11–16% <br> 2–3 | 14–20% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–6 February 2020](2020-02-06-Market.html) | Market | 36–42% <br> 7–9 | 16–22% <br> 3–4 | 13–18% <br> 2–3 | 15–20% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28–31 January 2020](2020-01-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–43% <br> 7–9 | 14–21% <br> 3–4 | 10–16% <br> 2–3 | 14–21% <br> 3–4 | 8–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–23 January 2020](2020-01-23-ResearchAffairs.html) | Research Affairs | 36–42% <br> 7–9 | 14–19% <br> 2–4 | 11–15% <br> 2–3 | 15–20% <br> 3–4 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–16 January 2020](2020-01-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 14–18% <br> 2–4 | 11–15% <br> 2–3 | 15–19% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–15 January 2020](2020-01-15-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 36–42% <br> 7–9 | 15–19% <br> 3–4 | 13–17% <br> 2–3 | 15–19% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–10 January 2020](2020-01-10-UniqueResearch.html) | Unique Research <br> profil | 35–41% <br> 7–9 | 14–19% <br> 2–4 | 14–19% <br> 2–4 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–9 January 2020](2020-01-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 15–20% <br> 3–4 | 11–15% <br> 2–3 | 15–20% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–19 December 2019](2019-12-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 15–20% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–19 December 2019](2019-12-19-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 16–22% <br> 3–4 | 12–17% <br> 2–3 | 14–19% <br> 2–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–13 December 2019](2019-12-13-UniqueResearch.html) | Unique Research <br> profil | 36–42% <br> 7–9 | 15–21% <br> 3–4 | 13–18% <br> 2–3 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–12 December 2019](2019-12-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29 November–5 December 2019](2019-12-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36–42% <br> 7–9 | 15–20% <br> 3–4 | 12–16% <br> 2–3 | 14–19% <br> 2–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29 November–4 December 2019](2019-12-04-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 16–21% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–28 November 2019](2019-11-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 16–21% <br> 3–4 | 12–16% <br> 2–3 | 14–19% <br> 2–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–21 November 2019](2019-11-21-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 18–23% <br> 3–5 | 12–16% <br> 2–3 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–15 November 2019](2019-11-15-UniqueResearch.html) | Unique Research <br> profil | 35–41% <br> 7–9 | 16–22% <br> 3–4 | 15–20% <br> 3–4 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–14 November 2019](2019-11-14-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 17–23% <br> 3–5 | 13–18% <br> 2–3 | 14–19% <br> 3–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–13 November 2019](2019-11-13-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 36–40% <br> 7–8 | 19–21% <br> 3–4 | 14–16% <br> 2–3 | 14–16% <br> 2–3 | 8–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–7 November 2019](2019-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 34–40% <br> 7–8 | 18–23% <br> 3–5 | 13–17% <br> 2–3 | 14–18% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [26–31 October 2019](2019-10-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 16–22% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–25 October 2019](2019-10-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 17–22% <br> 3–4 | 13–17% <br> 2–3 | 13–17% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 October 2019](2019-10-17-Market.html) | Market <br> Der Standard | 35–41% <br> 7–9 | 17–23% <br> 3–5 | 14–19% <br> 2–4 | 13–18% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–16 October 2019](2019-10-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 18–23% <br> 3–5 | 13–17% <br> 2–3 | 13–17% <br> 2–3 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–11 October 2019](2019-10-11-UniqueResearch.html) | Unique Research <br> profil | 34–40% <br> 7–8 | 17–23% <br> 3–5 | 15–20% <br> 3–4 | 13–18% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–23 September 2019](2019-09-23-OGM.html) | OGM <br> Servus TV | 31–37% <br> 6–8 | 20–25% <br> 4–5 | 18–23% <br> 3–5 | 10–14% <br> 2–3 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [19–22 September 2019](2019-09-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–37% <br> 6–8 | 20–26% <br> 4–5 | 19–24% <br> 4–5 | 9–13% <br> 2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [12–20 September 2019](2019-09-20-PeterHajek.html) | Peter Hajek <br> ATV, PULS 4 and Servus TV | 32–36% <br> 7–8 | 21–24% <br> 4–5 | 19–21% <br> 4 | 12–14% <br> 2–3 | 7–9% <br> 1–2 | 2–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [13–18 September 2019](2019-09-18-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–37% <br> 6–8 | 20–26% <br> 4–5 | 18–23% <br> 3–5 | 10–14% <br> 2–3 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [16–18 September 2019](2019-09-18-Market.html) | Market <br> Der Standard | 32–38% <br> 7–8 | 20–26% <br> 4–5 | 17–23% <br> 3–5 | 9–13% <br> 2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [1–18 September 2019](2019-09-18-InstitutfürGrundlagenforschung.html) | Institut für Grundlagenforschung | 29–35% <br> 6–7 | 16–22% <br> 3–4 | 23–29% <br> 5–6 | 9–14% <br> 1–3 | 6–10% <br> 1–2 | 2–5% <br> 0–1 | N/A <br> N/A | N/A <br> N/A |
| [11–17 September 2019](2019-09-17-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 32–36% <br> 7–8 | 21–24% <br> 4–5 | 19–21% <br> 4 | 12–14% <br> 2–3 | 8–10% <br> 1–2 | 1% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [2–13 September 2019](2019-09-13-UniqueResearch.html) | Unique Research <br> profil | 31–35% <br> 6–8 | 20–24% <br> 4–5 | 18–22% <br> 4 | 12–14% <br> 2–3 | 7–9% <br> 1–2 | 2–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [6–13 September 2019](2019-09-13-OGM.html) | OGM <br> KURIER | 33–37% <br> 7–8 | 20–24% <br> 4–5 | 18–22% <br> 4 | 10–12% <br> 2 | 7–9% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [6–11 September 2019](2019-09-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 19–26% <br> 4–5 | 16–23% <br> 3–5 | 9–14% <br> 1–3 | 7–12% <br> 1–2 | 0–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–10 September 2019](2019-09-10-KarmasinResearchIdentity.html) | Karmasin Research & Identity <br> PULS 24 | 33–37% <br> 7–8 | 21–24% <br> 4–5 | 18–20% <br> 3–4 | 11–13% <br> 2 | 8–10% <br> 1–2 | 2–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–8 September 2019](2019-09-08-Market.html) | Market <br> Der Standard | 31–37% <br> 6–8 | 19–25% <br> 4–5 | 18–24% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [30 August–4 September 2019](2019-09-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 6–8 | 19–26% <br> 4–5 | 17–24% <br> 3–5 | 8–14% <br> 1–3 | 6–11% <br> 1–2 | 0–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [2–4 September 2019](2019-09-04-Market.html) | Market <br> Der Standard | 31–37% <br> 6–8 | 19–25% <br> 4–5 | 18–24% <br> 4–5 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [29 August–3 September 2019](2019-09-03-KarmasinResearchIdentity.html) | Karmasin Research & Identity <br> PULS 24 | 33–37% <br> 7–8 | 20–22% <br> 4–5 | 19–21% <br> 4 | 11–13% <br> 2 | 8–10% <br> 1–2 | 1% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [22–28 August 2019](2019-08-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 6–8 | 18–26% <br> 4–5 | 17–24% <br> 3–5 | 8–14% <br> 1–3 | 6–11% <br> 1–2 | 1–4% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [19–22 August 2019](2019-08-22-UniqueResearch.html) | Unique Research <br> profil | 33–39% <br> 7–8 | 17–23% <br> 3–5 | 17–23% <br> 3–5 | 10–14% <br> 2–3 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [16–21 August 2019](2019-08-21-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 18–25% <br> 3–5 | 16–23% <br> 3–5 | 9–14% <br> 1–3 | 6–11% <br> 1–2 | 1–4% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [9–14 August 2019](2019-08-14-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31–39% <br> 6–8 | 18–25% <br> 3–5 | 16–23% <br> 3–5 | 9–14% <br> 1–3 | 7–12% <br> 1–2 | 1–4% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [8–12 August 2019](2019-08-12-OGM.html) | OGM <br> KURIER | 32–38% <br> 6–8 | 20–26% <br> 4–5 | 17–23% <br> 3–5 | 9–13% <br> 1–2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [26 July–9 August 2019](2019-08-09-KowarczMarktforschung.html) | Kowarcz Marktforschung | 29–33% <br> 6–7 | 18–22% <br> 4–5 | 20–24% <br> 4–5 | 11–15% <br> 2–3 | 8–11% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [1–7 August 2019](2019-08-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 7–9 | 19–26% <br> 4–5 | 17–24% <br> 3–5 | 8–13% <br> 1–2 | 6–11% <br> 1–2 | 1–4% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [2–5 August 2019](2019-08-05-Market.html) | Market <br> Der Standard | 32–38% <br> 6–8 | 19–25% <br> 4–5 | 17–23% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [25–31 July 2019](2019-07-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 7–8 | 19–26% <br> 4–5 | 17–24% <br> 3–5 | 9–14% <br> 1–3 | 6–11% <br> 1–2 | 0–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [18–24 July 2019](2019-07-24-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32–40% <br> 7–8 | 19–26% <br> 4–5 | 17–24% <br> 3–5 | 9–15% <br> 2–3 | 5–10% <br> 1–2 | 0–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–17 July 2019](2019-07-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 34–40% <br> 7–8 | 19–25% <br> 4–5 | 17–22% <br> 3–4 | 10–14% <br> 2–3 | 6–9% <br> 1 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [8–12 July 2019](2019-07-12-UniqueResearch.html) | Unique Research <br> profil | 34–40% <br> 7–8 | 17–23% <br> 3–5 | 18–24% <br> 3–5 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–10 July 2019](2019-07-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33–41% <br> 7–9 | 19–26% <br> 4–5 | 15–22% <br> 3–4 | 9–15% <br> 2–3 | 6–11% <br> 1–2 | 0–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [8–9 July 2019](2019-07-09-Market.html) | Market <br> Der Standard | 33–39% <br> 7–8 | 18–24% <br> 3–5 | 17–23% <br> 3–4 | 9–13% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [27 June–4 July 2019](2019-07-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 34–40% <br> 7–9 | 19–25% <br> 4–5 | 16–20% <br> 3–4 | 9–13% <br> 2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [24–28 June 2019](2019-06-28-PeterHajek.html) | Peter Hajek <br> ATV | 35–41% <br> 7–9 | 17–23% <br> 3–5 | 17–23% <br> 3–5 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [14–20 June 2019](2019-06-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 21–26% <br> 4–5 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [31 May–10 June 2019](2019-06-10-SORA.html) | SORA <br> ORF | 35–41% <br> 7–9 | 19–24% <br> 4–5 | 16–20% <br> 3–4 | 10–14% <br> 2–3 | 7–10% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–6 June 2019](2019-06-06-Market.html) | Market <br> Der Standard | 35–41% <br> 7–9 | 19–25% <br> 4–5 | 16–22% <br> 3–4 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [31 May–5 June 2019](2019-06-05-UniqueResearch.html) | Unique Research | 34–40% <br> 7–8 | 17–23% <br> 3–4 | 18–24% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [29 May–4 June 2019](2019-06-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35–41% <br> 7–9 | 20–26% <br> 4–5 | 15–19% <br> 3–4 | 7–11% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [29–31 May 2019](2019-05-31-UniqueResearch.html) | Unique Research | 35–41% <br> 7–9 | 18–24% <br> 3–5 | 17–22% <br> 3–4 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [29–31 May 2019](2019-05-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 34–42% <br> 7–9 | 20–27% <br> 4–6 | 14–21% <br> 3–4 | 6–11% <br> 1–2 | 8–13% <br> 1–2 | 0–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [1–31 May 2019](2019-05-31-DemoxResearch.html) | Demox Research | 35–41% <br> 7–9 | 20–25% <br> 4–5 | 16–21% <br> 3–4 | 7–10% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–29 May 2019](2019-05-29-OGM.html) | OGM <br> KURIER | 33–39% <br> 7–8 | 19–25% <br> 4–5 | 18–24% <br> 4–5 | 8–12% <br> 1–2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| 26 May 2019 | General Election | 34.6% <br> 7 | 23.9% <br> 5 | 17.2% <br> 3 | 14.1% <br> 2 | 8.4% <br> 1 | 1.0% <br> 0 | 0.0% <br> 0 | 0.0% <br> 0 |

Only polls for which at least the sample size has been published are included in the table above.

**Legend:**
+ **Top half of each row:** Voting intentions (95% confidence interval)
+ **Bottom half of each row:** Seat projections for the European Parliament (95% confidence interval)
+ **ÖVP:** Österreichische Volkspartei (EPP)
+ **SPÖ:** Sozialdemokratische Partei Österreichs (S&D)
+ **FPÖ:** Freiheitliche Partei Österreichs (ID)
+ **Grüne:** Die Grünen–Die Grüne Alternative (Greens/EFA)
+ **NEOS:** NEOS–Das Neue Österreich und Liberales Forum (RE)
+ **JETZT:** JETZT–Liste Pilz (Greens/EFA)
+ **GILT:** Meine Stimme Gilt! (*)
+ **HC:** Team HC Strache–Allianz für Österreich (*)
+ **N/A (single party):** Party not included the published results
+ **N/A (entire row):** Calculation for this opinion poll not started yet

